Robert Metzger
Family · Dallas, TXNPI 1447257159
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $965, 2.3 times the $411 reported in 2021. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $99.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$601
- Amgen$462
- Teva Pharmaceuticals USA, Inc.$449
- AbbVie$233
- Bayer$233
- Alnylam Pharmaceuticals Inc.$216
- plus $2K from 16 others
What the payments were for
- Food & beverage$3,895100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 6 | $601 |
| Amgen | 4 | $462 |
| Teva Pharmaceuticals USA, Inc. | 4 | $449 |
| AbbVie | 3 | $233 |
| Bayer | 3 | $233 |
| Alnylam Pharmaceuticals Inc. | 2 | $216 |
| Boehringer Ingelheim | 2 | $206 |
| Abbott | 1 | $153 |
| Kyowa Kirin, Inc. | 1 | $140 |
| Neurelis, Inc. | 1 | $125 |
| AstraZeneca | 1 | $120 |
| Grifols USA, LLC | 1 | $116 |
| Ultragenyx Pharmaceutical Inc. | 1 | $107 |
| Sumitomo Pharma America, Inc. | 1 | $105 |
| Kowa Pharmaceuticals America, Inc. | 1 | $95 |
| Lilly USA, LLC | 1 | $87 |
| Novo Nordisk | 1 | $87 |
| Stemline Therapeutics Inc. | 1 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $82 |
| Edwards Lifesciences | 1 | $81 |
| Medtronic | 1 | $71 |
| Paratek Pharmaceuticals, Inc. | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$363
- FREESTYLE LIBRE 3$153
- Austedo XR$135
- VALTOCO$125
- JARDIANCE$123
- FABRAZYME$122
- CEREZYME$122
- CERDELGA$122
- FARXIGA$120
- Prolastin-C Liquid$116
- ArmonAir Digihaler$115
- ProAir Digihaler$115
- AirDuo RespiClick$115
- AUSTEDO$111
- AMVUTTRA$108
- ONPATTRO$108
- CRYSVITA$107
- GEMTESA$105
- VRAYLAR$104
How this compares
$3,895 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Other family in Dallas
- David WeirDallas$959K
- Sie ThomasDallas$197K
- Marcia HarrisDallas$156K
- Miles HortonDallas$72K
- Natasha SimmonsDallas$38K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.